Home/Filings/4/0000874716-25-000029
4//SEC Filing

Smith Martin Alexander 4

Accession 0000874716-25-000029

CIK 0000874716other

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 9:43 PM ET

Size

25.6 KB

Accession

0000874716-25-000029

Insider Transaction Report

Form 4
Period: 2025-02-13
Smith Martin Alexander
Executive Vice President
Transactions
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2025-02-13+6,3206,320 total
    Exercise: $459.76Exp: 2035-02-12Common Stock (6,320 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-14+148682.95 total
  • Exercise/Conversion

    Common Stock

    2025-02-14+5931,275.95 total
  • Exercise/Conversion

    Common Stock

    2025-02-14+1891,464.95 total
  • Exercise/Conversion

    Common Stock

    2025-02-14+3011,765.95 total
  • Tax Payment

    Common Stock

    2025-02-14$444.53/sh374$166,2541,391.95 total
  • Award

    Incentive Stock Option (right-to-buy)

    2025-02-13+217217 total
    Exercise: $459.76Exp: 2035-02-12Common Stock (217 underlying)
  • Award

    Restricted Stock Unit

    2025-02-13+1,4681,468 total
    Common Stock (1,468 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-145930 total
    Common Stock (593 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14301903 total
    Common Stock (301 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14148148 total
    Common Stock (148 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-14189376 total
    Common Stock (189 underlying)
Footnotes (8)
  • [F1]Includes a total of 25 shares purchased under the Issuer Employee Stock Purchase Plan on September 30, 2024 and December 31, 2024.
  • [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
  • [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
  • [F4]Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
  • [F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023.
  • [F6]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2025.
  • [F7]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
  • [F8]Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001621358

Filing Metadata

Form type
4
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 9:43 PM ET
Size
25.6 KB